Arrowhead Pharmaceuticals (STU:HDP1) Accumulated Depreciation : €-45.97 Mil (As of Mar. 2024)

View and export this data going back to 1997. Start your Free Trial

What is Arrowhead Pharmaceuticals Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Arrowhead Pharmaceuticals's quarterly accumulated depreciation increased from Sep. 2023 (€-39.31 Mil) to Dec. 2023 (€-41.99 Mil) and increased from Dec. 2023 (€-41.99 Mil) to Mar. 2024 (€-45.97 Mil).

Arrowhead Pharmaceuticals's annual accumulated depreciation increased from Sep. 2021 (€-19.43 Mil) to Sep. 2022 (€-31.87 Mil) and increased from Sep. 2022 (€-31.87 Mil) to Sep. 2023 (€-39.31 Mil).

Arrowhead Pharmaceuticals Accumulated Depreciation Historical Data

The historical data trend for Arrowhead Pharmaceuticals's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arrowhead Pharmaceuticals Accumulated Depreciation Chart

Arrowhead Pharmaceuticals Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Accumulated Depreciation

Get a 7-Day Free Trial

-10.97

-13.84

-19.43

-31.87

-39.31

Arrowhead Pharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accumulated Depreciation	Get a 7-Day Free Trial															-33.69	-35.92	-39.31	-41.99	-45.97

Arrowhead Pharmaceuticals Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

Arrowhead Pharmaceuticals Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of Arrowhead Pharmaceuticals's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.

Arrowhead Pharmaceuticals (STU:HDP1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arrowhead Pharmaceuticals Inc (STU:HDP1) » Definitions » Accumulated Depreciation

Comparable Companies

Traded in Other Exchanges

ARWR:USA

Address

177 E. Colorado Boulevard, Suite 700, Pasadena, CA, USA, 91105

Website

https://www.arrowheadpharma.com

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.

Arrowhead Pharmaceuticals (STU:HDP1) Headlines

No Headlines